SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001016504-14-000002
Filing Date
2014-02-12
Accepted
2014-02-12 17:06:24
Documents
26
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 inb10q_20131231.htm 10-Q 190515
2 exhibit31_1.htm EX-31.1 12162
3 exhibit31_2.htm EX-31.2 11937
4 exhibit32_1.htm EX-32.1 5615
5 exhibit32_2.htm EX-32.2 5636
6 inb001.jpg GRAPHIC 173240
7 inb002.jpg GRAPHIC 140192
8 inb003a.jpg GRAPHIC 170853
9 inb004.jpg GRAPHIC 36748
10 inb005.jpg GRAPHIC 18230
11 inb006.jpg GRAPHIC 40965
12 inb007.jpg GRAPHIC 15206
13 inb008.jpg GRAPHIC 32398
14 inb009.jpg GRAPHIC 117213
15 inb010.jpg GRAPHIC 32198
16 inb003b.jpg GRAPHIC 30293
17 inb011.jpg GRAPHIC 24644
18 inb012.jpg GRAPHIC 54572
19 inb013.jpg GRAPHIC 53835
20 inb014.jpg GRAPHIC 25337
21 inb015.jpg GRAPHIC 80899
22 inb016.jpg GRAPHIC 73396
23 inb017.jpg GRAPHIC 24016
24 inb018.jpg GRAPHIC 71714
25 inb019.jpg GRAPHIC 23667
26 inb020.jpg GRAPHIC 35230
  Complete submission text file 0001016504-14-000002.txt   1985908
Mailing Address 201 ROUTE 22 HILLSIDE NJ 07205
Business Address 201 ROUTE 22 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31668 | Film No.: 14601248
SIC: 2834 Pharmaceutical Preparations